Chimerix to Report Third Quarter 2024 Financial Results and Provide an Operational Update on November 7, 2024


DURHAM, N.C., Nov. 01, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced that it will host a live conference call and audio webcast on Thursday, November 7, 2024 at 8:30 a.m. ET to report financial results for the third quarter ended September 30, 2024, and to provide a business overview.

Read the rest here:
Chimerix to Report Third Quarter 2024 Financial Results and Provide an Operational Update on November 7, 2024

Related Posts